Investment Thesis
Founding Felpel Ventures
Felpel Venture is a U.S focused investment firm, operating as an independent arm of the Felpel family office in Poland. Felpel Venture backs founders who drive innovation with purpose while leveraging a strong legacy of entrepreneurship and strategic investing.
Healthcare
Drawing from the family office’s deep experience in the pharmaceutical industry in Poland and broader European markets, Felpel Venture invests in biotech, digital health, and next-generation therapeutics to support healthcare innovation.
Tech-Agnostic
Rooted in Tomasz Felpel’s experience as a serial entrepreneur and investor in technology startups, Felpel Venture seeks disruptive software, AI-driven platforms, and scalable digital solutions across industries.
Team
Joe Park – Life Sciences, Senior Advisor
Joe Park – Life Sciences, Senior Advisor
Joe Park – Life Sciences, Senior Advisor
Joe is a seasoned healthcare and business leader with over 20 years of experience involving life sciences, corporate development, and venture capital. He holds a MBA from Columbia Business School. Joe played a pivotal role in the $1.3 billion sale of Modifi Biosciences to Merck, leading the business operations.
Paul Kwak – Venture Partner
Joe Park – Life Sciences, Senior Advisor
Joe Park – Life Sciences, Senior Advisor
Paul brings a wealth of experience in data analytics, corporate strategy, and defense operations to Felpel Venture. As a Service Area Manager at Technomics, he leads data-driven initiatives across federal agencies, focusing on national security and defense programs
Natalia Felpel – Associate
Joe Park – Life Sciences, Senior Advisor
Natalia Felpel – Associate
Natalia is an emerging leader in impact investing, venture capital, and financial strategy, with a strong focus on sustainable investments and innovative business models. She holds a background in finance and investment analysis, having worked with global firms on market research, strategic investments, and ESG-focused financial initiatives.